Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Birmingham-led team of geneticists decodes the inner workings of the zebrafish genome An international team of geneticists has created a comprehensive database defining the functions and properties of all gene regulatory elements in the zebrafish genome throughout fish development
07 January 2019 Leading scientist awarded £500,000 to investigate new blood test which could help spot bowel cancer sooner A leading University of Birmingham scientist has been awarded a £500,000 grant from Cancer Research UK to investigate whether a new blood-based screening test could detect bowel cancer earlier.
07 January 2019 Study identifies three simple 'clinical risks' and two biomarkers that could be used to screen patients with irregular heart rhythm Researchers at the University of Birmingham have found two biomarkers that could be used to identify a heart condition known as atrial fibrillation in patients who have three 'clinical risks'.
12 December 2018 Bernhard Baron Travelling Fellowship Prize awarded to Dr Jason Yap Dr Jason Yap has been awarded the Bernhard Baron Travelling Fellowship Prize from the Royal College of Obstetricians and Gynaecologists.
30 November 2018 Birmingham to lead brain cancer study in memory of Tessa Jowell Significant funding of up to £2.8 million from The Brain Tumour Charity has been awarded to a Birmingham researcher for a major study named in memory of the late Baroness Jowell.
15 November 2018 Standard chemotherapy treatment for HPV-positive throat cancer remains the most effective, study finds A new study funded by Cancer Research UK and led by the University of Birmingham has found that the standard chemotherapy used to treat a specific type of throat cancer remains the most effective.
05 November 2018 Farming family's fundraising legacy continues to support brain tumour patients A cheque in memory of Richard Watson Jones has been presented to the Queen Elizabeth Hospital Birmingham Charity to support the world-class care on offer for brain tumour patients at the hospital and the work of Professor Colin Watts, Chair of the Birmingham Brain Cancer Programme.
25 October 2018 Patients with HPV-positive throat cancer should receive chemotherapy not cetuximab Patients with human papilloma virus (HPV)-positive throat cancer should receive chemoradiotherapy rather than cetuximab with radiotherapy, according to research led by the University of Birmingham.
25 October 2018 Cancer trial shows treating the prostate with radiotherapy improves survival Treating the prostate with radiotherapy alongside standard treatment led to an 11 percent increase in survival for some men with advanced prostate cancer, according to study.
17 October 2018 Breast cancer drug could be used to treat life-threatening leukaemia A recently-approved breast cancer drug could be used to target and treat a life-threatening leukaemia, new research has revealed.
28 August 2018 Secretary of State for Health and Social Care visits Birmingham to see how cancer research is saving lives Matt Hancock, Secretary of State for Health and Social Care, met Cancer Research UK-funded scientists at the University of Birmingham today (Thursday, 23 August) to learn about their life-saving work.
21 August 2018 Birmingham cancer expert elected as first female President of BGCS The University of Birmingham women's cancer expert, Dr Sudha Sundar, has been chosen as the President-Elect of the British Gynaecological Cancer Society (BGCS), the first female gynaecological oncologist to be elected to this post.
06 August 2018 Bloodwise: Repairing the rope: how PARP inhibitors stop cancer Professor Tatjana Stankovic writes for the Bloodwise blog about a protein called PARP1 that can cause a build-up of DNA errors in some types of cancer.